487 related articles for article (PubMed ID: 32438732)
1. Revisiting Experimental Models of Diabetic Nephropathy.
Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
[TBL] [Abstract][Full Text] [Related]
2. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
3. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
4. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
Talukdar A; Basumatary M
Mol Biol Rep; 2023 Sep; 50(9):7759-7782. PubMed ID: 37458869
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
6. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
8. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
9. Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.
Hyvönen ME; Dumont V; Tienari J; Lehtonen E; Ustinov J; Havana M; Jalanko H; Otonkoski T; Miettinen PJ; Lehtonen S
Biomed Res Int; 2015; 2015():102969. PubMed ID: 26000279
[TBL] [Abstract][Full Text] [Related]
10. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
[TBL] [Abstract][Full Text] [Related]
11. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
12. Associations between structural and functional changes to the kidney in diabetic humans and mice.
Powell DW; Kenagy DN; Zheng S; Coventry SC; Xu J; Cai L; Carlson EC; Epstein PN
Life Sci; 2013 Aug; 93(7):257-64. PubMed ID: 23800643
[TBL] [Abstract][Full Text] [Related]
13. Animal Models of Diabetes-Associated Renal Injury.
Noshahr ZS; Salmani H; Khajavi Rad A; Sahebkar A
J Diabetes Res; 2020; 2020():9416419. PubMed ID: 32566684
[TBL] [Abstract][Full Text] [Related]
14. New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
Soler MJ; Riera M; Batlle D
Exp Diabetes Res; 2012; 2012():616313. PubMed ID: 22461787
[TBL] [Abstract][Full Text] [Related]
15. Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study.
Najafian B; Masood A; Malloy PC; Campos A; Hansen BC; Mauer M; Caramori ML
Diabetes Metab Res Rev; 2011 May; 27(4):341-7. PubMed ID: 21370383
[TBL] [Abstract][Full Text] [Related]
16. Development of late-stage diabetic nephropathy in OVE26 diabetic mice.
Zheng S; Noonan WT; Metreveli NS; Coventry S; Kralik PM; Carlson EC; Epstein PN
Diabetes; 2004 Dec; 53(12):3248-57. PubMed ID: 15561957
[TBL] [Abstract][Full Text] [Related]
17. Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice.
Wang L; Tang Y; Eisner W; Sparks MA; Buckley AF; Spurney RF
Biochem Biophys Res Commun; 2014 Feb; 444(4):622-7. PubMed ID: 24491571
[TBL] [Abstract][Full Text] [Related]
18. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
Huang F; Sheng XX; Zhang HJ
Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
[TBL] [Abstract][Full Text] [Related]
19. MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.
Ezquer ME; Ezquer FE; Arango-Rodríguez ML; Conget PA
Biol Res; 2012; 45(3):289-96. PubMed ID: 23283438
[TBL] [Abstract][Full Text] [Related]
20. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
